Table 2.
Non-Hispanic Black |
Non-Hispanic White |
|||
---|---|---|---|---|
Normotensive | Prehypertensive | Normotensive | Prehypertensive | |
n | 8 | 8 | 8 | 8 |
Baseline | ||||
Control | 15 ± 7 | 13 ± 9 | 17 ± 7 | 18 ± 11 |
Lidocaine | 13 ± 6 | 11 ± 4 | 12 ± 7 | 18 ± 9 |
l-NAME | 8 ± 4 | 10 ± 5 | 10 ± 2 | 14 ± 5 |
Lidocaine + l-NAME | 9 ± 4 | 13 ± 10 | 12 ± 5 | 15 ± 8 |
Maximal CVC | ||||
Control | 2.27 ± 0.81 | 2.30 ± 0.61 | 2.16 ± 0.69 | 2.03 ± 0.55 |
Lidocaine | 2.51 ± 0.52 | 2.62 ± 0.70 | 2.67 ± 0.62 | 2.60 ± 0.34 |
l-NAME | 2.30 ± 0.58 | 1.96 ± 0.55 | 2.25 ± 0.50 | 2.26 ± 0.51 |
Lidocaine + l-NAME | 2.52 ± 0.45 | 1.94 ± 0.56 | 2.02 ± 0.89 | 1.89 ± 0.58 |
Values are means ± SD. Baseline are maximal vasodilation (%CVCmax), and maximal values are cutaneous vascular conductance (CVC) (flux/mean arterial pressure). l-NAME, Nω-nitro-l-arginine methyl ester.